Study Shows Tarcocimab May Improve Diabetic Retinopathy : co

A phase 3 trial showed that tarcocimab, a biopolymer with a vascular growth factor antibody, improved vision and anatomical markers in patients with early stage diabetic retinopathy.

Related Keywords

Udine , Friuli Venezia Giulia , Italy , United States , Texas , American , Paolo Lanzetta , Charles Wykoff , Kodiak Sciences , University Of Udine , American Academy Of Ophthalmology , Blanton Eye Institute Of Houston Methodist Hospital , Retina Consultants , Blanton Eye Institute , Houston Methodist , American Academy , Diabetic Retinopathy Severity Scale , Retinal Disease , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , Type 2 Diabetes , Microvascular Complications Of Diabetes , Diabetic Retinopathy , Retinopathy , Monoclonal Antibody , Etuximab , Ituximab , Macular Edema , Diabetic Macular Edema , Clinical Management , Imbalance , Macular Degeneration , Ge Related Macular Degeneration Armd , Postoperative , Retina ,